@article {48,
	title = {A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer.},
	journal = {Cancer chemotherapy and pharmacology},
	volume = {68},
	year = {2011},
	month = {10/2011},
	pages = {1033-44},
	abstract = {PURPOSE: To investigate the mechanistic basis of the anti-tumor effect of the compound ITB-301.

METHODS: Chemical modifications of genistein have been introduced to improve its solubility and efficacy. The anti-tumor effects were tested in ovarian cancer cells using proliferation assays, cell cycle analysis, immunofluorescence, and microscopy.

RESULTS: In this work, we show that a unique glycoside of genistein, ITB-301, inhibits the proliferation of SKOv3 ovarian cancer cells. We found that the 50\% growth inhibitory concentration of ITB-301 in SKOv3 cells was 0.5~μM. Similar results were obtained in breast cancer, ovarian cancer, and acute myelogenous leukemia cell lines. ITB-301 induced significant time- and dose-dependent microtubule depolymerization. This depolymerization resulted in mitotic arrest and inhibited proliferation in all ovarian cancer cell lines examined including SKOv3, ES2, HeyA8, and HeyA8-MDR cells. The cytotoxic effect of ITB-301 was dependent on its induction of mitotic arrest as siRNA-mediated depletion of BUBR1 significantly reduced the cytotoxic effects of ITB-301, even at a concentration of 10~μM. Importantly, efflux-mediated drug resistance did not alter the cytotoxic effect of ITB-301 in two independent cancer cell models of drug resistance.

CONCLUSION: These results identify ITB-301 as a novel anti-tubulin agent that could be used in cancers that are multidrug resistant. We propose a structural model for the binding of ITB-301 to α- and β-tubulin dimers on the basis of molecular docking simulations. This model provides a rationale for future work aimed at designing of more potent analogs.},
	keywords = {Antineoplastic Agents, Cell Line, Tumor, Cell Proliferation, Dose-Response Relationship, Drug, Drug Resistance, Multiple, Drug Resistance, Neoplasm, Female, Genistein, Glycosides, Humans, Inhibitory Concentration 50, Microtubules, Mitosis, Models, Molecular, Molecular Dynamics Simulation, Ovarian Neoplasms, Protein Binding, Tubulin},
	issn = {1432-0843},
	doi = {10.1007/s00280-011-1575-2},
	author = {Ahmed, Ahmed Ashour and Goldsmith, Juliet and Fokt, Izabela and Le, Xiao-Feng and Krzy{\'s}ko, Krystiana A and Lesyng, Bogdan and Bast, Robert C and Priebe, Waldemar}
}
@article {43,
	title = {New tools and expanded data analysis capabilities at the Protein Structure Prediction Center.},
	journal = {Proteins},
	volume = {69 Suppl 8},
	year = {2007},
	month = {2007},
	pages = {19-26},
	abstract = {We outline the main tasks performed by the Protein Structure Prediction Center in support of the CASP7 experiment and provide a brief review of the major measures used in the automatic evaluation of predictions. We describe in more detail the software developed to facilitate analysis of modeling success over and beyond the available templates and the adopted Java-based tool enabling visualization of multiple structural superpositions between target and several models/templates. We also give an overview of the CASP infrastructure provided by the Center and discuss the organization of the results web pages available through http://predictioncenter.org.},
	keywords = {Computational Biology, Internet, Models, Molecular, Protein Conformation, Protein Folding, Proteins, Software, Structure-Activity Relationship},
	issn = {1097-0134},
	doi = {10.1002/prot.21653},
	author = {Kryshtafovych, Andriy and Prlic, Andreas and Dmytriv, Zinoviy and Daniluk, Pawe{\l} and Milostan, Maciej and Eyrich, Volker and Hubbard, Tim and Fidelis, Krzysztof}
}
@article {52,
	title = {Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment.},
	journal = {Experimental neurology},
	volume = {200},
	year = {2006},
	month = {2006 Jul},
	pages = {82-8},
	abstract = {Mutations in the amyloid precursor protein (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2) genes are associated with early-onset familial Alzheimer{\textquoteright}s disease (EOAD). There are several reports describing mutations in PSEN1 in cases with frontotemporal dementia (FTD). We identified two novel mutations in the PSEN1 gene: L226F and L424H. The first mutation was detected in a patient with a clinical diagnosis of FTD and a post-mortem diagnosis of AD. The second mutation is connected with a clinical phenotype of variant AD with strong FTD signs. In silico modeling revealed that the mutations, as well as mutations used for comparison (F177L and L424R), change the local structure, stability and/or properties of the transmembrane regions of the presenilin 1 protein (PS1). In contrast, a silent non-synonymous substitution F175S is eclipsed by external residues and has no influence on PS1 interfacial surface. We suggest that in silico analysis of PS1 substitutions can be used to characterize novel PSEN1 mutations, to discriminate between silent polymorphisms and a potential disease-causing mutation. We also propose that PSEN1 mutations should be considered in FTD patients with no MAPT mutations.},
	keywords = {Adult, Computational Biology, Dementia, Diagnosis, Differential, Female, Genetic Testing, Humans, Male, Membrane Proteins, Models, Molecular, Mutation, Phenotype, Presenilin-1},
	issn = {0014-4886},
	doi = {10.1016/j.expneurol.2006.01.022},
	author = {Zekanowski, Cezary and Golan, Maciej P and Krzy{\'s}ko, Krystiana A and Lipczy{\'n}ska-{\L}ojkowska, Wanda and Filipek, S{\l}awomir and Kowalska, Anna and Rossa, Grzegorz and Pep{\l}o{\'n}ska, Beata and Styczy{\'n}ska, Maria and Maruszak, Aleksandra and Religa, Dorota and Wender, Mieczys{\l}aw and Kulczycki, Jerzy and Barcikowska, Maria and Ku{\'z}nicki, Jacek}
}
@article {53,
	title = {A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface.},
	journal = {Photochemical \& photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology},
	volume = {3},
	year = {2004},
	month = {2004 Jun},
	pages = {628-38},
	abstract = {G protein-coupled receptors (GPCRs) are ubiquitous and essential in modulating virtually all physiological processes. These receptors share a similar structural design consisting of the seven-transmembrane alpha-helical segments. The active conformations of the receptors are stabilized by an agonist and couple to structurally highly conserved heterotrimeric G proteins. One of the most important unanswered questions is how GPCRs couple to their cognate G proteins. Phototransduction represents an excellent model system for understanding G protein signaling, owing to the high expression of rhodopsin in rod photoreceptors and the multidisciplinary experimental approaches used to study this GPCR. Here, we describe how a G protein (transducin) docks on to an oligomeric GPCR (rhodopsin), revealing structural details of this critical interface in the signal transduction process. This conceptual model takes into account recent structural information on the receptor and G protein, as well as oligomeric states of GPCRs.},
	keywords = {Animals, Dimerization, Models, Molecular, Protein Conformation, Protein Structure, Secondary, Receptors, G-Protein-Coupled, Rhodopsin},
	issn = {1474-905X},
	doi = {10.1039/b315661c},
	author = {Filipek, S{\l}awomir and Krzy{\'s}ko, Krystiana A and Fotiadis, Dimitrios and Liang, Yan and Saperstein, David A and Engel, Andreas and Palczewski, Krzysztof}
}
